Fucoidan enhances the therapeutic potential of arsenic trioxide and all-trans retinoic acid in acute promyelocytic leukemia, in vitro and in vivo.
about
Differences in cell death and cell cycle following fucoidan treatment in high-density HT-29 colon cancer cells.Role of Vitamin A/Retinoic Acid in Regulation of Embryonic and Adult Hematopoiesis.LRRC25 plays a key role in all-trans retinoic acid-induced granulocytic differentiation as a novel potential leukocyte differentiation antigen.
P2860
Fucoidan enhances the therapeutic potential of arsenic trioxide and all-trans retinoic acid in acute promyelocytic leukemia, in vitro and in vivo.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Fucoidan enhances the therapeu ...... eukemia, in vitro and in vivo.
@en
Fucoidan enhances the therapeu ...... eukemia, in vitro and in vivo.
@nl
type
label
Fucoidan enhances the therapeu ...... eukemia, in vitro and in vivo.
@en
Fucoidan enhances the therapeu ...... eukemia, in vitro and in vivo.
@nl
prefLabel
Fucoidan enhances the therapeu ...... eukemia, in vitro and in vivo.
@en
Fucoidan enhances the therapeu ...... eukemia, in vitro and in vivo.
@nl
P2860
P50
P356
P1433
P1476
Fucoidan enhances the therapeu ...... eukemia, in vitro and in vivo.
@en
P2093
Ray M Lowenthal
P2860
P304
46028-46041
P356
10.18632/ONCOTARGET.10016
P407
P577
2016-06-14T00:00:00Z